EM Envoy Medical, Inc. Stock: price and directors' dealings · United States · SEC (Form 4)Follow the Envoy Medical, Inc. share price and the full insider trade history of the company, a listed issuer based in United States. Shares are quoted on the US market, under the supervision of SEC (Form 4). Market capitalisation: €57m. The latest transaction was filed on 4 June 2026 (Attribution). Among the most active insiders: Lucas Brent T.. All data is free.
Analyst consensus: bullish or bearish? Analysts rate Envoy Medical, Inc. Strong Buy (bullish), based on 2 analysts. Average price target: US$2.25.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ Sigma AI Analysis Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 4 June 2026
All Executives27 Thresholds0 Prospectus0 Other0
Declarations 27 total
◆ Chief Executive Officer · Executives · 29 May 2026
32,856 shares @ US$0.599 0.031% mcap 65.4% of flow Class A Common Stock SEC:0000914190-26-000095:0
18,750,000 shares @ US$0.40 100.0% of flow Class A Common Stock SEC:0001104659-26-016182:0
Canonical exit: 13 May 2026 (T+90) ▲ Director · Executives · 12 Feb 2026
312,500 shares @ US$0.40 81.3% of flow Class A Common Stock SEC:0000914190-26-000028:0
Canonical exit: 13 May 2026 (T+90) ▲ Interim CFO · Executives · 12 Feb 2026
212,500 shares @ US$0.40 100.0% of flow Class A Common Stock SEC:0000914190-26-000027:0
Canonical exit: 13 May 2026 (T+90) ▲ Director · Executives · 12 Feb 2026
96,150 shares @ US$0.40 100.0% of flow Class A Common Stock SEC:0000914190-26-000026:0
Canonical exit: 13 May 2026 (T+90) ▲ Director · Executives · 12 Feb 2026
1,000,000 shares @ US$0.40 100.0% of flow Class A Common Stock SEC:0000914190-26-000025:0
Canonical exit: 13 May 2026 (T+90) ▲ Chief Executive Officer · Executives · 12 Feb 2026
62,500 shares @ US$0.40 31.2% of flow Class A Common Stock SEC:0000914190-26-000024:0
Canonical exit: 13 May 2026 (T+90) ◆ Chief Executive Officer · Executives · 28 Nov 2025
18,105 shares @ US$0.713 23.9% of flow Class A Common Stock SEC:0000914190-25-000054:0
▲ Director · Executives · 11 Jun 2025
2,500 shares @ US$1.47 13.2% of flow Class A Common Stock SEC:0001062993-25-011661:0
Canonical exit: 9 Sept 2025 (T+90) ▲ Director · Executives · 6 Jun 2025
10,000 shares @ US$1.46 60.6% of flow Class A Common Stock SEC:0001062993-25-011320:0
Canonical exit: 4 Sept 2025 (T+90) ◆ Chief Executive Officer · Executives · 30 Nov 2024
5,165 shares @ US$1.94 26.8% of flow Class A Common Stock SEC:0001062993-25-011296:0
▲ Director · Executives · 22 May 2025
2,000 shares @ US$1.6834 0.7% of flow Class A Common Stock SEC:0001062993-25-010396:0
Canonical exit: 20 Aug 2025 (T+90) ▲ Director · Executives · 23 May 2025
13,000 shares @ US$1.6433 4.6% of flow Class A Common Stock SEC:0001062993-25-010396:1
Canonical exit: 21 Aug 2025 (T+90) ▲ Director · Executives · 27 May 2025
35,000 shares @ US$1.6478 12.4% of flow Class A Common Stock SEC:0001062993-25-010396:2
Canonical exit: 25 Aug 2025 (T+90) ● Director · Executives · 23 Dec 2024
34,705 shares 0Class A Common Stock SEC:0001140361-24-050422:0
1,028,986 shares 0Class A Common Stock, par value $0.0001 per share SEC:0001140361-24-050420:0
▲ Director · Executives · 20 Nov 2024
2,500 shares @ US$2.2795 64.9% of flow Class A Common Stock SEC:0001062993-24-019574:0
Canonical exit: 18 Feb 2025 (T+90) ● Director · Executives · 19 Nov 2024
18,182 shares 0Class A Common Stock SEC:0001062993-24-019530:0
1,000,000 shares 0Class A Common Stock, par value $0.0001 per share SEC:0001062993-24-019529:0
▲ Director · Executives · 9 Sept 2024
1,000 shares @ US$3.20 35.1% of flow Class A Common Stock SEC:0001062993-24-016486:0
Canonical exit: 8 Dec 2024 (T+90) ● Chief Executive Officer · Executives · 24 Jun 2024
74,784 shares 0Class A Common Stock SEC:0001062993-24-013065:0
▲ Chief Executive Officer · Executives · 21 Nov 2023
10,000 shares @ US$0.98 100.0% of flow Class A Common Stock SEC:0001062993-23-021438:0
Canonical exit: 19 Feb 2024 (T+90) ● Director · Executives · 29 Sept 2023
25,000 shares Class A Common Stock, par value $0.0001 per share SEC:0001062993-23-018935:0
2,490,000 shares Class A Common Stock, par value $0.0001 per share SEC:0001062993-23-018937:0
● Director · Executives · 29 Sept 2023
25,000 shares 0Class A Common Stock, par value $0.0001 per share SEC:0001062993-23-018936:0
25 of 27 declarations
Load more (2 remaining) About Envoy Medical, Inc. Envoy Medical, Inc. is a company focused on developing innovative medical solutions. It is listed on the XNAS market.